دورية أكاديمية
An Intervention to Reduce Drinking Among Individuals With HIV and Hepatitis C: A Pilot Randomized Controlled Trial.
| العنوان: | An Intervention to Reduce Drinking Among Individuals With HIV and Hepatitis C: A Pilot Randomized Controlled Trial. |
|---|---|
| المؤلفون: | Elliott JC; Department of Psychology, Molloy University, Rockville Centre, New York.; New York State Psychiatric Institute, New York, New York.; Department of Psychiatry, Columbia University Medical Center, New York, New York., Ali M; New York State Psychiatric Institute, New York, New York., Radecka O; New York State Psychiatric Institute, New York, New York., Lerias D; New York State Psychiatric Institute, New York, New York., Shalev N; Division of Infectious Diseases, Columbia University Medical Center, New York, New York., Stohl M; New York State Psychiatric Institute, New York, New York., Aharonovich E; New York State Psychiatric Institute, New York, New York.; Department of Psychiatry, Columbia University Medical Center, New York, New York., Hasin DS; New York State Psychiatric Institute, New York, New York.; Department of Psychiatry, Columbia University Medical Center, New York, New York.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. |
| المصدر: | Journal of studies on alcohol and drugs [J Stud Alcohol Drugs] 2024 Mar; Vol. 85 (2), pp. 227-233. Date of Electronic Publication: 2023 Nov 02. |
| نوع المنشور: | Randomized Controlled Trial; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Alcohol Research Documentation, Inc., Rutgers, The State University of New Jersey Country of Publication: United States NLM ID: 101295847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-4114 (Electronic) Linking ISSN: 19371888 NLM ISO Abbreviation: J Stud Alcohol Drugs Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Piscataway, NJ : Alcohol Research Documentation, Inc., Rutgers, The State University of New Jersey, c2007- |
| مواضيع طبية MeSH: | Coinfection* , Hepatitis C*/epidemiology , Hepatitis C*/prevention & control , HIV Infections*/epidemiology , HIV Infections*/prevention & control, Humans ; Alcohol Drinking/epidemiology ; Alcohol Drinking/prevention & control ; Pilot Projects ; Hepacivirus |
| مستخلص: | Objective: Heavy drinking poses serious risks to individuals with HIV, hepatitis C virus (HCV), and especially HIV/HCV coinfection. We adapted the National Institute on Alcohol Abuse and Alcoholism Clinician's Guide to address HIV/HCV coinfection and paired this with the "HealthCall" smartphone app to create an intervention tailored to HIV/HCV. After formative work and pretesting with HIV/HCV coinfected heavy drinkers, we conducted a pilot trial to determine potential of this new intervention for decreasing drinking. Method: A sample of 31 HIV/HCV coinfected heavy drinkers were randomly assigned to either intervention ( n = 16) or control ( n = 15; psychoeducation and brief advice) conditions. All participants completed a 60-day program consisting of approximately 25-minute-long baseline sessions and brief 5-10-minute booster sessions at 30 and 60 days, as well as an assessment-only follow-up at 90 days. Outcomes were measured using the Timeline Followback at baseline, 30, 60, and 90 days. Generalized linear models were used for analysis. Results: Intervention participants drank fewer mean drinks per drinking day at 60 days (incidence rate ratio [IRR] = 0.43, p = .03) and 90 days (IRR = 0.34, p < .01). Intervention participants also reported fewer drinking days at 90 days (mean difference = 34.5%; p < .01). Self-efficacy differed between groups during intervention ( p < .05). Conclusions: Although our sample was small, our results suggested lower drinking among participants who received a modified Clinician's Guide intervention plus use of the smartphone app HealthCall, in comparison with education and advice alone. A larger study is indicated to further examine this brief, disseminable intervention for HIV/HCV coinfected drinkers. |
| References: | Curr HIV/AIDS Rep. 2013 Dec;10(4):356-70. (PMID: 23990322) World J Clin Cases. 2021 Nov 26;9(33):10052-10063. (PMID: 34904075) Drug Alcohol Depend. 2010 Dec 1;112(3):178-93. (PMID: 20705402) J Subst Abuse Treat. 2019 Nov;106:97-106. (PMID: 31540617) AIDS Behav. 2017 Nov;21(Suppl 2):126-143. (PMID: 28831609) J Health Psychol. 2018 May;23(6):829-839. (PMID: 27577039) Soc Work Public Health. 2016 Oct;31(6):565-73. (PMID: 27295132) Addict Behav. 1999 Nov-Dec;24(6):879-92. (PMID: 10628520) Behav Res Ther. 2000 Dec;38(12):1211-20. (PMID: 11104185) Addiction. 2013 Jul;108(7):1230-40. (PMID: 23432593) J Subst Use. 2016;21(3):294-297. (PMID: 27293379) Drug Alcohol Depend. 2015 Mar 1;148:27-33. (PMID: 25595052) Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072. (PMID: 27696523) AIDS Behav. 2021 Apr;25(4):1013-1025. (PMID: 33047258) AIDS Behav. 2021 Dec;25(Suppl 3):251-264. (PMID: 33950339) Psychol Assess. 2020 Mar;32(3):254-264. (PMID: 31697110) J Stud Alcohol. 1995 Mar;56(2):168-72. (PMID: 7760562) Syst Rev. 2019 Oct 28;8(1):244. (PMID: 31661030) J Subst Abuse Treat. 2022 Jul;138:108733. (PMID: 35131124) Alcohol Res Health. 2010;33(3):267-79. (PMID: 23584068) J Psychoactive Drugs. 2005 Dec;37(4):401-8. (PMID: 16480167) Addict Sci Clin Pract. 2014 Feb 17;9:5. (PMID: 24533631) AIDS Rev. 2022;25(2):87-96. (PMID: 35901073) Front Immunol. 2021 Aug 12;12:726419. (PMID: 34456931) |
| معلومات مُعتمدة: | K23 AA023753 United States AA NIAAA NIH HHS |
| تواريخ الأحداث: | Date Created: 20231110 Date Completed: 20240312 Latest Revision: 20240317 |
| رمز التحديث: | 20240317 |
| مُعرف محوري في PubMed: | PMC10941824 |
| DOI: | 10.15288/jsad.23-00010 |
| PMID: | 37947429 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1938-4114 |
|---|---|
| DOI: | 10.15288/jsad.23-00010 |